Skip to content

FP7

PROTECT

Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium

Programme
Seventh Framework Programme
Started
Ends
Duration
68 months
Total cost
EUR 28,617,382
EU contribution
EUR 11,009,715
Participants
32 from 11 countries
Topic
FP7_IMI-JU-01-2008-06
Grant agreement
115004

Coordinated by The European Medicines Agency (NLNetherlands).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
The European Medicines AgencyNLNetherlandsCoordinatorEUR 396,258PIC (1.00)
AmgenBEBelgiumParticipantNot statedPIC (1.00)
Novartis Pharma AGCHSwitzerlandParticipantNot statedPIC (1.00)
Outcome Europe SarlCHSwitzerlandParticipantEUR 983,677PIC (1.00)
Bayer Pharma AGDEGermanyParticipantNot statedPIC (1.00)
Ludwig-Maximilians-Universitaet MuenchenDEGermanyParticipantEUR 346,803PIC (1.00)
Merck Kommanditgesellschaft Auf AktienDEGermanyParticipantNot statedPIC (1.00)
Private Universitaet Witten/Herdecke gGmbHDEGermanyParticipantEUR 38,820PIC (1.00)
Aarhus UniversitetDKDenmarkParticipantEUR 322,087known name (0.95)
Danish Health and Medicines AuthorityDKDenmarkParticipantEUR 752,294PIC (1.00)
H. Lundbeck AsDKDenmarkParticipantNot statedPIC (1.00)
Novo Nordisk A/SDKDenmarkParticipantNot statedPIC (1.00)
Agencia Espanola de Medicamentos y Productos SanitariosESSpainParticipantEUR 374,520known name (0.95)
Fundacio' Institut Català de FarmacologiaESSpainParticipantEUR 622,643PIC (1.00)
Fundación Centro Español de Investigación FarmacoepidemiológicaESSpainParticipantEUR 280,450PIC (1.00)
Institut National de la Sante et de la Recherche MedicaleFRFranceParticipantEUR 539,760known name (0.95)
L.A Sante, Epidemiologie, Evaluation et Recherche L.A.S.E.R.FRFranceParticipantEUR 1,400,657PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantNot statedPIC (1.00)
Department of HealthGBUnited KingdomParticipantEUR 492,896known name (0.95)
Eli Lilly and Company LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantNot statedPIC (1.00)
Imperial College of Science Technology and MedicineGBUnited KingdomParticipantEUR 767,316PIC (1.00)
International Alliance of Patients’ OrganizationsGBUnited KingdomParticipantEUR 116,294PIC (1.00)
Takeda Development Centre Europe LtdGBUnited KingdomParticipantNot statedPIC (1.00)
Istituto di Ricerche Farmacologiche Mario NegriITItalyParticipantEUR 232,500PIC (1.00)
Academisch Ziekenhuis GroningenNLNetherlandsParticipantEUR 268,604PIC (1.00)
Genzyme Europe B.V.NLNetherlandsParticipantNot statedPIC (1.00)
Rijksuniversiteit GroningenNLNetherlandsParticipantEUR 329,741known name (0.95)
Universiteit UtrechtNLNetherlandsParticipantEUR 1,428,695known name (0.95)
Uniwersytet Medyczny Im Karola Marcinkowskiego w PoznaniuPLPolandParticipantEUR 57,014known name (0.97)
Astrazeneca ABSESwedenParticipantNot statedPIC (1.00)
Stiftelsen WHO Collaborating Centre for International Drug MonitoringSESwedenParticipantEUR 1,013,796PIC (1.00)

Changes of the consortium

First seen on with 32 participants from 11 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.